Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jacobi

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Molecular Metabolism|October 17, 2017
Macrophage alternative activation confers protection against lipotoxicity-induced cell deathLingling Dai, Prerna Bhargava, Kristopher J Stanya, et al.
Cell Metabolism|September 15, 2015
Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic FitnessDavid Jacobi, Sihao Liu, Kristopher Burkewitz, et al.
Urologia Internationalis|June 16, 2026
Mapping Digital Transformation in Ambulatory Urology in Germany: High Familiarity versus Low Connectivity - A Nationwide Survey on the Current State, Structural Barriers, and Economic FrameworkJulian Risch, David Jacobi, Jakob Kohler, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Cognitive Behaviour Therapy|June 18, 2019
Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD)Davíð R M A Højgaard, Sophie C Schneider, Valérie La Buissonnière-Ariza, et al.
The Journal of Clinical Investigation|December 22, 2012
Direct control of hepatic glucose production by interleukin-13 in miceKristopher J Stanya, David Jacobi, Sihao Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 9, 2021
Timing of Kidney Clamping and Deceased Donor Kidney Transplant OutcomesSimon Ville, Marine Lorent, Clarisse Kerleau, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Diabetes, Obesity & Metabolism|March 26, 2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical TrialsPierre Bel Lassen, David Jacobi, Marie-Claude Brindisi, et al.
Science (New York, N.Y.)|May 2, 2020
Interleukin-13 drives metabolic conditioning of muscle to endurance exerciseNelson H Knudsen, Kristopher J Stanya, Alexander L Hyde, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Molecular Metabolism|October 17, 2017
Macrophage alternative activation confers protection against lipotoxicity-induced cell deathLingling Dai, Prerna Bhargava, Kristopher J Stanya, et al.
Cell Metabolism|September 15, 2015
Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic FitnessDavid Jacobi, Sihao Liu, Kristopher Burkewitz, et al.
Urologia Internationalis|June 16, 2026
Mapping Digital Transformation in Ambulatory Urology in Germany: High Familiarity versus Low Connectivity - A Nationwide Survey on the Current State, Structural Barriers, and Economic FrameworkJulian Risch, David Jacobi, Jakob Kohler, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Cognitive Behaviour Therapy|June 18, 2019
Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD)Davíð R M A Højgaard, Sophie C Schneider, Valérie La Buissonnière-Ariza, et al.
The Journal of Clinical Investigation|December 22, 2012
Direct control of hepatic glucose production by interleukin-13 in miceKristopher J Stanya, David Jacobi, Sihao Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 9, 2021
Timing of Kidney Clamping and Deceased Donor Kidney Transplant OutcomesSimon Ville, Marine Lorent, Clarisse Kerleau, et al.
Diabetes & Metabolism|February 19, 2025
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety dataEmmanuel Disse, Judith Aron-Wisnewsky, David Jacobi, et al.
Diabetes, Obesity & Metabolism|March 26, 2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical TrialsPierre Bel Lassen, David Jacobi, Marie-Claude Brindisi, et al.
Science (New York, N.Y.)|May 2, 2020
Interleukin-13 drives metabolic conditioning of muscle to endurance exerciseNelson H Knudsen, Kristopher J Stanya, Alexander L Hyde, et al.
Pageof 6